Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 3 analysts offering 12 month price targets for China Shineway Pharmaceutical Group Ltd have a median target of 11.01, with a high estimate of 18.02 and a low estimate of 10.01. The median estimate represents a 31.98% increase from the last price of 8.34.
High | 116.0% | 18.02 |
Med | 32.0% | 11.01 |
Low | 20.0% | 10.01 |
Dividends
Div growth (TTM) | 26.57% |
---|
More ▼
Earnings history & estimates in CNY
Average growth rate | +19.58% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +14.10% |
More ▼